IndiaTickerLatest filing: Vivimed Labs Ltd - 532660 - Announcement under Regulation 30 (LODR)-Newspaper Publication
ObservedCompany dossier
Vivimed Labs
NSE:VIVIMEDLAB · ISIN INE526G01021
- Close
- ₹5.29 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Vivimed Labs
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹36.5 Cr · PAT ₹-6 Cr.
Exchange XBRLLatest ownership: promoter group 7.57% and public 92.43% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Vivimed Labs Ltd - 532660 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Observed
Source filing Vivimed Labs Ltd - 532660 - Re- Lodgement Of Transfer Requests
BSE · exchange filing
Observed
Source filing Updates - Vivimed Labs Limited
NSE · exchange filing
Observed
Source filing General Updates - Vivimed Labs Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹36.5 Cr
- Profit after tax
- ₹-6 Cr
- EPS
- ₹-0.72
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- 7.57%
- Public
- 92.43%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL